FDA — authorised 20 December 2024
- Application: NDA218730
- Marketing authorisation holder: VERTEX PHARMS INC
- Local brand name: ALYFTREK
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Alyftrek in United States
FDA authorised Alyftrek on 20 December 2024
Marketing authorisations
FDA
- Marketing authorisation holder: VERTEX PHARMS INC
- Status: approved
Alyftrek in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Alyftrek approved in United States?
Yes. FDA authorised it on 20 December 2024; FDA has authorised it.
Who is the marketing authorisation holder for Alyftrek in United States?
VERTEX PHARMS INC holds the US marketing authorisation.